港交所陈翊庭，重磅发声！

Core Viewpoint - Hong Kong Stock Exchange is processing over 200 listing applications, with nearly half being technology companies [15][20]. Market Performance - On September 5, Hong Kong's three major stock indices rose across the board, with the Hang Seng Index up 1.43% to 25,417.98 points, and the Hang Seng Tech Index up 1.95% to 5,687.45 points [2]. - The Hang Seng Biotechnology Index saw a strong rebound, rising 4.67% to 17,943.37 points, with a peak increase of 5.04% during the day [3][4]. Notable Stock Movements - Major biotech stocks experienced significant gains, with companies like Sanofi Biotech rising 18.24%, Ark Health rising 14.88%, and Kangnuo Ya rising 14.53% [5][6]. - Lithium stocks also surged, with Tianqi Lithium up 13.33% and Ganfeng Lithium up 12.55% [6]. Sector Performance - In the Hang Seng Index, 76 stocks rose while 7 fell, with notable gainers including Xinyi Solar up 7.54% and China Biopharmaceutical up 6.20% [7][8]. - The Hang Seng Composite Industry Index showed strong performance, with the materials sector up 5.3% and healthcare up 4.2% [10]. New Listings and Financing - The new stock issuance scale has significantly increased, with total financing reaching HKD 134.5 billion by the end of August, nearly six times the amount from the same period in 2024 [19]. - The "A+H" listing model has been particularly prominent, accounting for 70% of total financing in the first half of the year, indicating strong market linkage between mainland and Hong Kong [19]. Technology Sector Insights - The Hong Kong Stock Exchange is currently processing 24 listing applications from biotech companies under Chapter 18A and 12 applications from specialized technology companies under Chapter 18C, covering various cutting-edge fields such as visual intelligence and robotics [20].